ArticleChembiochem : a European journal of chemical biology2025
Chemical Surface Modification Tolerance of Primary and Immortalized Macrophages and Stem Cells.
Article in Chembiochem : a European journal of chemical biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Cells are being utilized across various applications, including as self-regenerating materials, imaging and/or therapeutic entities, and delivery vehicles, and have the potential to do more. In biological and medical applications, specific cell types, including macrophages and mesenchymal stem cells (MSCs), have often been used on account of their recruitment to disease sites and desirable biodistribution properties. Typically, delivery applications involve the internalization of substrates within the cell, however, this approach presents drawbacks and is not amenable to some uses. Alternatively, chemically modifying cell surfaces using the toolbox of biocompatible chemistries has been broadly applied, but with few direct comparisons, including regarding assessment(s) of effects on the cells. In this work, we sought to compare commonly utilized N-hydroxysuccinimide ester and hydrazide-based conjugations to immortalized and primary macrophages and MSCs. We incorporated both small molecules and avidin proteins using each approach, finding that cargo size plays a substantial role in modifications. Overall, conjugations were well-tolerated by primary and immortalized macrophages and MSCs; we observed no major impacts on viability and chemotactic response, but found some slight changes and trends depending on cell and modification type. This foundational work directly comparing the results and effects of multiple conjugation strategies across different cell types will benefit their use across a variety of applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.